Skip to Content

GG 614 GG 614 (Ranitidine Hydrochloride 150 mg)

Pill with imprint GG 614 GG 614 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; cutaneous mastocytosis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 614 GG 614

Ranitidine hydrochloride 150 mg GG 614 GG 614
Ranitidine hydrochloride 150 mg GG 614 GG 614 Front
Ranitidine hydrochloride 150 mg GG 614 GG 614 Back
Ranitidine hydrochloride 150 mg GG 614 GG 614

Ranitidine Hydrochloride

Imprint:
GG 614 GG 614
Strength:
150 mg
Color:
Brown
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
ammonia
corn starch
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide